Simultaneous determination of citalopram and its metabolite in human plasma by LC-MS/MS applied to pharmacokinetic study.

Tao Jiang,Zhengxing Rong,Liang Peng,Bing Chen,Yifan Xie,Congying Chen,Jing Sun,Yiping Xu,Yang Lu,Hongzhuan Chen

DOI: https://doi.org/10.1016/j.jchromb.2010.01.004

IF: 3.318

2010-01-01

Journal of Chromatography B

Abstract:A simple sensitive and robust method for simultaneous determination of citalopram and desmethylcitalopram was developed using liquid chromatography tandem mass spectrometry (LC–MS/MS). A 200μL aliquot of plasma sample was employed and deproteinized with methanol and desipramine was used as the internal standard. After vortex mixing and centrifugation, the supernatant was diluted with water (1:1, v/v) and then directly injected to analysis. Analytes were separated by a Zorbax XDB C18 column with the mobile phase composed of acetonitrile and water (30:70, v/v) with 0.25% formic acid and monitored in MRM mode using a positive electrospray source with tandem mass spectrometry detection. The total run time was 3.5min. The dynamic range was 0.2–100ng/mL for citalopram and 0.25–50ng/mL for desmethylcitalopram, respectively. Compared to the best existing literatures for plasma samples, the same LOQ for CIT (0.5ng/mL) and lower LOQ for DCIT (0.25 vs 5ng/mL) were reached, and less sample preparation steps and runtime (3.5 vs 10min) were taken for our method. Accuracy and precision was lower than 8% and lower than 11.5% for either target. Validation results and its application to the analysis of plasma samples after oral administration of citalopram in healthy Chinese volunteers demonstrated the method was applicable to pharmacokinetic studies.